What are the most attractive biotech stocks right now for investors? Seeking Alpha analysts offer their picks. Read more here.
Investor's Business Daily on MSN
Travere, IBD stock of the day, is on path to $3 billion and in a buy zone
Travere Therapeutics is Thursday's IBD Stock Of The Day. Shares are lingering around a buy zone after gapping up on an FDA ...
Travere Therapeutics Inc. Annual cash flow by MarketWatch. View TVTX net cash flow, operating cash flow, operating expenses and cash dividends.
Ligand Pharmaceuticals Inc () has held its Q1 earnings call. Read on for the main highlights of the call. Meet Samuel – Your Personal Investing Prophet. Start a conversation wit ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
AstraZeneca's Oncology and Rare Disease segments delivered 16% and 15% growth, powered by IMFINZI and ULTOMIRIS, respectively ...
In the last week, the United States market has stayed flat, yet it is up 27% over the past year with earnings expected to grow by 17% per annum in the coming years. In this context, identifying stocks ...
Investor's Business Daily on MSN
Merck stock zooms closer to a breakout on 'a new chapter' in cancer
Merck stock popped early Friday after European officials recommended approving its combination for a form of bladder cancer.
The United States market has shown a steady performance, remaining flat over the last week but achieving a 24% increase over the past year, with earnings projected to grow by 17% annually. In such an ...
Kirk Campbell, MD, discusses why FSGS is traditionally difficult to treat, the significance of the sparsentan approval, and future access needs. He discussed the longstanding challenges of treating ...
TPG Mortgage Investment Trust Inc. 8% Pfd. Series B (MITT.PRB) XNYS Mortgage REITs TPG Mortgage Investment Trust Inc. 8% Pfd. Series C (MITT.PRC) XNYS Mortgage REITs TPG Mortgage Investment Trust Inc.
The total number of shares of a security that have been sold short and not yet repurchased. Change from Last Percentage change in short interest from the previous report to the most recent report.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results